Association of cardiovascular risk factors with markers of endothelial dysfunction in middle-aged men and women

Summary

Endothelial dysfunction plays an important role in the pathogenesis of cardiovascular diseases and diabetes mellitus. However, the causes underlying endothelial dysfunction are not fully understood. Therefore, the aim of the present study was to investigate associations of cardiovascular risk factors with soluble adhesion molecules (sE-Selectin, sICAM-1), soluble thrombomodulin (sTM) and von Willebrand factor (vWF) as markers of endothelial dysfunction. The study population consisted of a subcohort of 2,168 men and women aged 35 to 74 years randomly drawn from three cross-sectional population-based MONICA/ KORA Augsburg surveys conducted between 1984 and 1995. In multivariable linear regression analysis, current smoking, high (versus moderate) alcohol consumption, ratio of total cholesterol/HDL-cholesterol (TC/HDL-C) and C-reactive protein (CRP) were significantly associated with elevated levels of sEselectin and sICAM-1. Increased levels of sE-selectin were also found in subjects with actual hypertension, high body mass index and prevalent diabetes mellitus. In addition, low physical activity and no (versus moderate) alcohol consumption were significantly associated with elevated concentrations of sICAM-1. Levels of sTM were higher in subjects with actual hypertension, no or high amounts of alcohol intake and a high ratio of TC/ HDL-C, but were lower in subjects witha history of myocardial infarction. VWF was significantly associated with CRP only. In conclusion, sE-selectin and sICAM-1 are more strongly associated with traditional cardiovascular risk factors than sTM and vWF.

Keywords

endothelial dysfunction - sE-selectin - sICAM-1 - thrombomodulin - vWF - cardiovascular risk factors

• References

• 1 Ross R. Atherosclerosis – an inflammatory disease. N Engl J Med 1999; 340: 115-26.
• 2 Pinkney JH, Stehouwer CDA, Coppack SW. et al. Endothelial Dysfunction: Cause of the Insulin Resistance Syndrome. Diabetes 1997; 46 (Suppl. 02) S9-S13.
• 3 Blann A, Seigneur M. Soluble markers of endothelial cell function. Clin Hemorheol Microcirc 1997; 17: 3-11.
• 4 Blankenberg S, Barbaux S, Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis 2003; 170: 191-203.
• 5 Duncan BB, Schmidt MI, Offenbacher S. et al. Factor VIII and other hemostasis variables are related to incident diabetes in adults. The Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care 1999; 22: 767-72.
• 6 Meigs JB, Hu FB, Rifai N. et al. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 2004; 291: 1978-86.
• 7 Blann AD, Seigneur M, Steiner M. et al. Circulating endothelial cell markers in peripheral vascular disease: relationship to the location and extent of atherosclerotic disease. Eur J Clin Invest 1997; 27: 916-21.
• 8 Blann AD, Amiral J, McCollum CN. Prognostic value of increased soluble thrombomodulin and increased soluble E-selectin in ischaemic heart disease. Eur J Haematol 1997; 59: 115-20.
• 9 Salomaa V, Matei C, Aleksic N. et al. Soluble thrombomodulin as a predictor of incident coronary heart disease and symptomless carotid artery atherosclerosis in the Atherosclerosis Risk in Communities (ARIC) Study: a case-cohort study. Lancet 1999; 353: 1729-34.
• 10 Morange PE, Simon C, Alessi MC. et al. Endothelial cell markers and the risk of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) study. Circulation 2004; 109: 1343-8.
• 11 Rohde LE, Hennekens CH, Ridker PM. Cross-sectional study of soluble intercellular adhesion molecule-1 and cardiovascular risk factors in apparently healthy men. Arterioscler Thromb Vasc Biol 1999; 19: 1595-9.
• 12 Keaney Jr. JF, Massaro JM, Larson MG. et al. Heritability and correlates of intercellular adhesion molecule-1 in the Framingham Offspring Study. J Am Coll Cardiol 2004; 44: 168-73.
• 13 Folsom AR, Conlan MG, Davis CE. et al. Relations between hemostasis variables and cardiovascular risk factors in middle-aged adults. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Ann Epidemiol 1992; 02: 481-94.
• 14 Conlan MG, Folsom AR, Finch A. et al. Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost 1993; 70: 380-5.
• 15 Kumari M, Marmot M, Brunner E. Social determinants of von Willebrand factor: the Whitehall II study. Arterioscler Thromb Vasc Biol 2000; 20: 1842-7.
• 16 Demerath E, Towne B, Blangero J. et al. The relationship of soluble ICAM-1, VCAM-1, P-selectin and E-selectin to cardiovascular disease risk factors in healthy men and women. Ann Hum Biol 2001; 28: 664-78.
• 17 Ponthieux A, Herbeth B, Droesch S. et al. Biological determinants of serum ICAM-1, E-selectin, P-selectin and L-selectin levels in healthy subjects: the Stanislas study. Atherosclerosis 2004; 172: 299-308.
• 18 WHO MONICA Project Principal Investigators (prepared by H. Tunstall-Pedoe). The World Health Organization MONICA Project (Monitoring of Trends and Determinants in Cardiovascular Disease): A major international collaboration. J Clin Epidemiol 1988; 34: 105-14.
• 19 Hense HW, Filipiak B, Döring A. et al. Ten-year trends of cardiovascular risk factors in the MONICA Augsburg Region in Southern Germany. Results from the 1984/85, 1989/90 and 1994/1995 surveys. CVD Prevention 1998; 01: 318-27.
• 20 Meisinger C, Thorand B, Schneider A. et al. Sex differences in risk factors for incident type 2 diabetes mellitus– The MONICA Augsburg cohort study. Arch Intern Med 2002; 162: 82-9.
• 21 Hutchinson WL, Koenig W, Fröhlich M. et al. Immunoradiometric assay of circulating C-reactive protein: age-related values in the adult general population. Clin Chem 2000; 46: 934-8.
• 22 Khuseyinova N, Imhof A, Trischler G. et al. Determination of C-reactive protein: comparison of three high-sensitivity immunoassays. Clin Chem 2003; 49: 1691-5.
• 23 SAS Institute Inc. SAS/STAT User’s Guide, Version 8. Cary, USA: SAS Institute Inc; 1999: 3215-71.
• 24 SAS Institute Inc. SAS/STAT User’s Guide, Version 9.1. Cary, USA: SAS Institute Inc; 2004: 4183-239.
• 25 Nasr A, Breckwoldt M. Estrogen replacement therapy and cardiovascular protection: lipid mechanisms are the tip of an iceberg. Gynecol Endocrinol 1998; 12: 43-59.
• 26 Oparil S, Arthur C. Corcoran Memorial Lecture. Hormones and vasoprotection. Hypertension 1999; 33: 170-6.
• 27 Hwang SJ, Ballantyne CM, Sharrett AR. et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation 1997; 96: 4219-25.
• 28 Blann AD, McCollum CN, Lip GY. Relationship between plasma markers of endothelial cell integrity and the Framingham cardiovascular disease risk-factor scores in apparently healthy individuals. Blood Coagul Fibrinolysis 2002; 13: 513-8.
• 29 Hotamisligil GS, Arner P, Caro JF. et al. Increased adipose tissue expression of tumor necrosis factoralpha in human obesity and insulin resistance. J Clin Invest 1995; 95: 2409-15.
• 30 Mohamed-Ali V, Goodrick S, Rawesh A. et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo . J Clin Endocrinol Metab 1997; 82: 4196-200.
• 31 Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000; 102: 2165-8.
• 32 Verma S, Wang CH, Li SH. et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 2002; 106: 913-9.
• 33 Sacanella E, Badia E, Nicolas JM. et al. Differential effects of moderate or heavy alcohol consumption on circulating adhesion molecule levels. Thromb Haemost 2002; 88: 52-5.
• 34 Imhof A, Froehlich M, Brenner H. et al. Effect of alcohol consumption on systemic markers of inflammation. Lancet 2001; 357: 763-7.
• 35 Volpato S, Pahor M, Ferrucci L. et al. Relationship of alcohol intake with inflammatory markers and plasminogen activator inhibitor-1 in well-functioning older adults: the Health, Aging, and Body Composition study. Circulation 2004; 109: 607-12.
• 36 McCarty MF. Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: downregulation with essential fatty acids, ethanol and pentoxifylline. Med Hypotheses 1999; 52: 465-77.
• 37 Marmot M, Brunner E. Alcohol and cardiovascular disease: the status of the U shaped curve. BMJ 1991; 303: 565-8.
• 38 Suvorava T, Lauer N, Kojda G. Physical inactivity causes endothelial dysfunction in healthy young mice. J Am Coll Cardiol 2004; 44: 1320-7.
• 39 McCarron RM, Wang L, Siren AL. et al. Adhesion molecules on normotensive and hypertensive rat brain endothelial cells. Proc Soc Exp Biol Med 1994; 205: 257-62.
• 40 Cockerill GW, Rye KA, Gamble JR. et al. High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Arterioscler Thromb Vasc Biol 1995; 15: 1987-94.
• 41 Weyer C, Yudkin JS, Stehouwer CD. et al. Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians. Atherosclerosis 2002; 161: 233-42.
• 42 Galajda P, Martinka E, Mokan M. et al. Endothelial markers in diabetes mellitus. Thromb Res 1997; 85: 63-5.
• 43 Krakoff J, Funahashi T, Stehouwer CDA. et al. Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian. Diabetes Care 2003; 26: 1745-51.